American Journal of Ophthalmology
Volume 142, Issue 5 , Pages 745-749.e2, November 2006

Atopic Disease and Herpes Simplex Eye Disease: A Population-Based Case-Control Study

  • Tisha Prabriputaloong, MD

      Affiliations

    • Department Francis I. Proctor Foundation, University of California San Francisco, San Francisco, California
    • Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
    • ,
  • Todd P. Margolis, MD, PhD

      Affiliations

    • Department Francis I. Proctor Foundation, University of California San Francisco, San Francisco, California
    • ,
  • Thomas M. Lietman, MD

      Affiliations

    • Department Francis I. Proctor Foundation, University of California San Francisco, San Francisco, California
    • ,
  • Ira G. Wong, MD, MS

      Affiliations

    • Department Francis I. Proctor Foundation, University of California San Francisco, San Francisco, California
    • Department of Ophthalmology, Stanford University, Stanford, California
    • ,
  • Rookaya Mather, MD

      Affiliations

    • Department Francis I. Proctor Foundation, University of California San Francisco, San Francisco, California
    • Department of Ophthalmology, The University of Western Ontario, London, Ontario, Canada
    • ,
  • David C. Gritz, MD, MPH

      Affiliations

    • Department Francis I. Proctor Foundation, University of California San Francisco, San Francisco, California
    • Department of Ophthalmology, The Permanente Medical Group, Kaiser Permanente Medical Center, Oakland, Richmond, California.
    • Corresponding Author InformationInquiries to David C. Gritz, MD, MPH, 280 W. MacArthur Blvd., Oakland, CA 94611

Accepted 19 June 2006. published online 27 July 2006.

Purpose

To determine whether atopy is associated with herpes simplex virus (HSV) ocular disease.

Design

Retrospective, population-based, case-control study.

Methods

setting: Large, regional health maintenance organization (Northern California Kaiser Permanente). study Population: 1,042,351 people over a one-year period. observation Procedures: Electronic database search for HSV ocular disease and subsequent chart review determined study eligibility. Two age-matched control groups (one population-based and one clinic-based) were randomly chosen. Medical record review determined the presence of atopy. Severe atopic disease was defined by diagnostic code or illness requiring an emergency room visit, hospitalization, or treatment with a systemic corticosteroid. main Outcome Measures: Presence of HSV eye disease, presence of atopy, and characterization of atopy severity.

Results

HSV eye disease was found in 172 patients. HSV cases had a greater prevalence of atopy (34%, 58/172) than the clinic-based (25%, 43/172) or the population-based controls (21%, 36/172, odds ratio (OR) 1.5, 95% confidence interval (CI) 0.9 to 2.6 and OR 1.9, 95%, CI 1.1 to 3.3, respectively). The association of HSV ocular disease with severe atopy was even greater, with a history of severe atopic disease in 13% (22/172) of patients with HSV ocular disease as compared with 6% (11/172) of patients in the clinic control group and 3% (5/172) of patients in the population control group (OR 2.0, 95% CI 0.7 to 5.9 and OR 4.8, 95% CI 1.6 to 19.2, respectively).

Conclusions

Patients with HSV ocular disease are more likely to have a history of atopic disease, especially severe atopic disease, than age-matched controls.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by Cecilia Vaughn Fellowship (T.P.), Direct Community Benefit Investment Kaiser Research Foundation Institute (D.C.G.), NIH Grants EY02162 and EY 10008 (T.P.M.), The Peierls Foundation, and a Research to Prevent Blindness Senior Scientific Investigator Award (T.P.M.).

PII: S0002-9394(06)00775-6

doi:10.1016/j.ajo.2006.06.050

American Journal of Ophthalmology
Volume 142, Issue 5 , Pages 745-749.e2, November 2006

Article Tools